Synthesis and biological evaluation of phosphonate derivatives of some acyclic pyridine-C-nucleosides

Nucleosides and Nucleotides

Volumn 17, Issue 12, 1998, Pages 2429-2443

  Van Hemel, Johan ^a   Esmans, Eddy L ^a   Joos, Pieter E ^a   De Groot, Alex ^a   Dommisse, Roger A ^a   Balzarini, Jan M ^b   De Clercq, Erik D ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

9 [2 (PHOSPHONOMETHOXY)ETHYL]NUCLEOTIDE DERIVATIVE; 9 [2 (PHOSPHONYLMETHOXY)PROPYL]NUCLEOTIDE DERIVATIVE; 9 [3 HYDROXY 2 (PHOSPHONOMETHOXY)PROPYL] NUCLEOTIDE DERIVATIVE; ACICLOVIR; ANTIVIRUS AGENT; NUCLEOTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; NUCLEOTIDE METABOLISM; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TANDEM MASS SPECTROMETRY; VARICELLA ZOSTER VIRUS;

HUMAN HERPESVIRUS 3; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 0031784582     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319808004329     Document Type: Article

References (15)

1. E. De Clercq, A. Holy, I. Rosenberg, T. Sakuma, J. Balzarini, P.C. Maudgal; Nature, 323, 464 (1986).
2. E. De Clercq, T. Sakuma, M. Baba, R. Pauwels, J. Balzarini, I. Rosenberg, A. Holy; Antiviral Res., 8, 261 (1987).
3. J. Balzarini, A. Holy, J. Jindrich, L. Naessens, R. Snoeck, D. Schols, E. De Clercq; Antimicrob. Agents Chemother., 37, 332 (1993).
4. J.J. Bronson, I. Ghazzouli, M.J.M. Hitchcock, R.R. Webb, J.C. Martin; J. Med. Chem., 32, 1457 (1989).
5. E. De Clercq, A. Holy, I. Rosenberg, T. Sakuma, J. Balzarini, P.C. Maudgal; Nature, 323, 464 (1986).
6. E. De Clercq, T. Sakuma, B. Masanori, R. Pauwels, J. Balzarini; I. Rosenberg, A. Holy; Antiviral Res., 8, 261 (1987).
7. R. Snoeck, G. Andrei, E. De Clercq; Eur. J. Clin. Microbiol. Infect Dis., 15, 574 (1996).
8. R. Snoeck, G. Andrei, M. Gérard, A. Silverman, A. Hedderman, J. Balzarini, C. Sadzot-Delvaux, G. Tricot, E. De Clercq; Clin. Infect. Dis., 18, 570 (1994).
9. G. Andrei, R. Snoeck, M. Vandeputte, E. De Clercq; Antimicrob. Agents Chemother., 41, 587 (1997).
10. E. Van Cutsem, R. Snoeck, M. Van Ranst, P. Fiten, G. Opdenakker, K. Geboes, J. Janssens, P. Rutgeerts, G. Vantrappen, E. De Clercq; J. Med. Virol., 45, 230 (1995).
11. L. Naesens, R. Snoeck, G. Andrei, J. Baizarini, J. Neyts, E. De Clercq; Antiviral Chem. Chemother., 8, 1 (1997).
12. C.C. Kim, P.F. Misco, B.Y. Luh, M.J.M. Hitchcock, I. Ghazzouli, J.C. Martin; J. Med. Chem., 34, 2286 (1991).
13. J. Van hemel, E.L. Esmans, F.C. Alderweireldt, R.A. Dommisse, A. De Groot, J. Baizarini, E. De Clercq; Nucleos. Nucleot., 13, 2345 (1994).
14. J. Van hemel, E.L. Esmans, A. De Groot, R.A. Dommisse, J.M. Baizarini, E.D. De Clercq; Nucleos. Nucleot., 15, 1203 (1996).
15. J.J. Bronson, L.M. Ferrara, H.G. Howell, P.R. Brodfuehrer, J.C. Martin; Nucleos. Nucleot., 9, 745 (1990).